Considerations for Patient and Target Selection in Deep Brain Stimulation Surgery for Parkinson’s Disease

  title={Considerations for Patient and Target Selection in Deep Brain Stimulation Surgery for Parkinson’s Disease},
  author={Robert Francis Dallapiazza and Philippe De Vloo and Anton Fomenko and Darrin J. Lee and Clement Hamani and Renato Puppi Munhoz and Mojgan Hodaie and Andres M. Lozano and Alfonso Fasano and Suneil K. Kalia},
  journal={Parkinson’s Disease: Pathogenesis and Clinical Aspects},
ABSTRACT Deep brain stimulation (DBS) is an effective treatment for improving motor symptoms of Parkinson’s disease among well-selected patients. Over the past 30 years, several anatomical regions have been targeted with DBS based on prior experience in lesional neurosurgery and characteristic changes in subcor­tical motor regulation in Parkinson’s disease. In this chapter, we provide an overview of the patient selection process and surgical procedure for DBS. We also discuss the various… 

Figures and Tables from this paper

Deep Brain Stimulation in Parkinson’s Disease: Assessing Efficacy
  • F. Somaa
  • Medicine
    Research and Reviews in Parkinsonism
  • 2021
The review assesses the efficacy of different parameters involved in selection of DBS as a treatment strategy such as patient characteristics, target characteristics, pros and cons of different DBS strategies, safety ofDBS and stage of PD to help clinicians to effectively use all these parameters to improve the outcomes.
Current and future directions of deep brain stimulation for neurological and psychiatric disorders.
Despite the value of DBS, future developments should be aimed at developing less invasive techniques and attaining not just symptom improvement but curative disease modification.
Treatment Options for Motor and Non-Motor Symptoms of Parkinson’s Disease
  • F. Church
  • Psychology, Medicine
  • 2021
The best strategy for treating PD is to hope to slow disorder progression and strive to achieve stability with neuroprotection, an integrative medicine and health strategy that highlights five treatment options for people with Parkinson’s.
Acute low frequency dorsal subthalamic nucleus stimulation improves verbal fluency in Parkinson's disease
Parkinson’s Disease Rehabilitation: Effectiveness Approaches and New Perspectives
Using traditional or technological approaches, physical therapy has reached good results in improving motor and nonmotor functions, as well as the quality of life of Parkinsonians, but it is important to develop and to fortify the physical therapy approach so that it can provide stronger evidence about the practice.
Estimulación cerebral profunda para la enfermedad de Parkinson: criterios de selección, abordaje quirúrgico, efectos secundarios y controversias.
A descriptive review of the selection process, the surgical intervention, theurgical complications, and the controversies on Parkinson’s disease, which is the second most common neurodegenerative disease.


Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
DBS leads placed using the ClearPoint real-time interventional MRI-guided methodology for deep brain stimulation (DBS) lead placement resulted in highly accurate lead placement and outcomes comparable to those seen with frame-based approaches.
Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.
Patients with Parkinson's disease had similar improvement in motor function after either pallidal or subthalamic stimulation, and nonmotor factors may reasonably be included in the selection of surgical target for deep-brain stimulation.
DBS Candidates That Fall Short on a Levodopa Challenge Test: Alternative and Important Indications
Although motor response to levodopa remains the primary selection criteria for DBS candidacy in Parkinson disease, patients who do not meet the 30% threshold and have disabling symptoms may still benefit from DBS.
Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study.
Pallidal and STN stimulation appears to be safe and efficacious for the management of advanced PD, with significant differences in symptom response and the interaction of L-dopa with stimulation at either site.
Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
The overall assessment indicates a high antiparkinsonian effect of DBS of the STN even in advanced patients, and the existence of a learning curve for this procedure should be taken into account when initial results are evaluated.
Effect of advancing age on outcomes of deep brain stimulation for Parkinson disease.
The findings suggest that age alone should not be a primary exclusion factor for determining candidacy for DBS and a clear focus on patients with medication-refractory and difficult to control on-off fluctuations with preserved cognition, regardless of age, may allow for an expansion of the traditional therapeutic window.
Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease.
The results show a positive antiparkinsonian effect of pallidal DBS, and electrode insertion alone resulted in measurable clinical effects in the absence of stimulation.
A randomized trial of deep-brain stimulation for Parkinson's disease.
In this six-month study of patients under 75 years of age with severe motor complications of Parkinson's disease, neurostimulation of the subthalamic nucleus was more effective than medical management alone.
Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease
STN DBS is a promising new surgical option for the treatment of advanced Parkinson's Disease and the marked clinical benefits obtained in these severely disabled patients outweighed the adverse effects.
Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
Evidence is provided that stimulation-induced motor improvement was sustained overall at 10 years, although part of the initial benefit wore off mainly because of progressive loss of benefit on axial signs over time.